MTD:NYE-Mettler-Toledo International Inc. (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 1155.52

Change

0.00 (0.00)%

Market Cap

USD 10.87B

Volume

0.32M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Mettler-Toledo International Inc is engaged in the supply of precision instruments and services. It is a provider of weighing instruments for use in laboratory, industrial and food retailing applications.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-0.67 (-0.35%)

USD 140.35B
A Agilent Technologies Inc

-0.87 (-0.78%)

USD 32.44B
IQV IQVIA Holdings Inc

-1.23 (-0.88%)

USD 24.71B
LH Laboratory Corporation of Amer..

-1.12 (-0.45%)

USD 20.88B
DGX Quest Diagnostics Incorporated

+1.06 (+0.61%)

USD 19.12B
QGEN Qiagen NV

-0.23 (-0.51%)

USD 9.05B
CRL Charles River Laboratories

-0.59 (-0.44%)

USD 6.92B
ENZ Enzo Biochem Inc

-0.01 (-1.94%)

USD 0.02B
TMO Thermo Fisher Scientific Inc

-6.35 (-1.58%)

N/A
WAT Waters Corporation

-5.56 (-1.59%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

N/A

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
IBB iShares Biotechnology ETF 2.80 % 0.47 %

+1.99 (+0%)

USD 5.11B
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

-0.03 (0%)

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

-0.18 (0%)

N/A
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

+0.25 (+0%)

N/A
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.57% 75% C 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.57% 75% C 27% F
Trailing 12 Months  
Capital Gain -17.70% 50% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.70% 50% F 15% F
Trailing 5 Years  
Capital Gain 43.82% 73% C 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.82% 73% C 47% F
Average Annual (5 Year Horizon)  
Capital Gain 7.42% 85% B 65% D
Dividend Return 7.42% 85% B 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 24.63% 62% D 38% F
Risk Adjusted Return 30.12% 69% C- 49% F
Market Capitalization 10.87B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike